What Is Tirzepatide and How Does It Help with Weight Loss?
Tirzepatide dosage chart for weight loss is an injectable medication used to reduce excess body weight, treat obstructive sleep apnea (OSA), and control blood sugar levels. Unlike other weight loss management injections, most of which are GLP-1 receptor agonists, it has a powerful double action, as a GLP-1 and GIP receptor agonist.
GLP-1 and GIP are hormones that work after you eat. Tirzepatide mimics their action:
- Reduces hunger.
- Keeps food in the stomach longer, making you feel satisfied with smaller portions.
- Lowers cravings for sugars and carbs.
- Lowers blood glucose levels by helping the body to burn glucose.
Tirzepatide brand names you may recognize are Zepbound and Mounjaro.
- Mounjaro is registered to control blood sugar in adults with type 2 diabetes.
- Zepbound is approved for weight management and sleep apnea in adults who meet certain requirements.
However, Mounjaro is sometimes used off-label for weight loss, and Zepbound may be used off-label for managing blood sugar.
Branded Tirzepatide vs. Compounded Versions
Due to high demand, licensed pharmacies make ‘compounded’ versions of the original medication. However, unlike branded medicines, these compounds are not FDA-approved because no clinical trials have tested their safety and effectiveness.
Tirzepatide Dosing for Weight Loss
Here are the approved tirzepatide dosage instructions for weight management taken from the Zepbound prescribing information.
Four basic rules to know about this Tirzepatide dosage chart for weight loss medication are to take it:
- Once a week
- On the same day each week.
- At any time of day.
- With or without a meal.
Starting Dose of Tirzepatide
The recommended starting dose of tirzepatide is 2.5 mg weekly. An individual stays on the starting dose for a minimum of 4 weeks.
Tirzepatide Dose Escalation Schedule
Your healthcare provider will decide when to increase the tirzepatide dose, but never earlier than every 4 weeks, and then only by 2.5 mg at a time.
2.5 mg → 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg
The maximum recommended dose is 15 mg once weekly.
Tirzepatide Maintenance Dose After Weight Loss
The recommended tirzepatide doses for maintenance of weight loss are 5 mg, 10 mg, or 15 mg weekly, depending on a person’s response.
Importantly, not everyone needs to reach the maximum tirzepatide dose to lose weight; rather, you should stay at a lower dose if it’s working, with no side effects.
To find your Tirzepatide dosage chart for weight loss, your healthcare provider will follow up with you every 4 weeks and check two things when you reach each recommended maintenance dose:
- Are you still having side effects?
- Are you experiencing significant weight loss yet?
If the answer to both is no, they will continue to up-titrate the dose by 2.5 mg every 4 weeks until reaching the next weight loss maintenance dose.
Something else to note is that the typical maintenance doses for other indications differ from those of weight loss:
- Diabetes type 2 :Any dose between 5 mg and 15 mg weekly, at 2.5 mg increases, depending on blood sugar control.
- Sleep apnea: 10 mg or 15 mg weekly.
Why Does Tirzepatide Dosage Start Low and Increase Gradually?
For all indications, healthcare providers start at a low tirzepatide dose and increase it very slowly to help your body adjust to the medication.
Unfortunately, even at low doses, side effects are common. However, they are dose dependent. This means that the higher the dose, the more severe the side effects usually are. So, when you start at a lower dose, you’re more likely to tolerate the side effects.
Branded Tirzepatide Dosage Chart
Tirzepatide dosage chart for weight lossdosage guide simplifies the dosing regimen for the branded tirzepatide (Zepbound and Mounjaro) and will help you plan appropriate clinical follow-up appointment dates.
Note that this tirzepatide dosing schedule is provided for informational purposes only; everyone responds to medication differently, so remember to discuss and follow personalized recommendations from your healthcare provider.
| Week | Dose (mg) | Finding the correct dose |
| 1-4 | 2.5 | Starting dose |
| 5-8 | 5 | Increase if tolerated and needed |
| 9-12 | 7.5 | Increase if tolerated |
| 13-16 | 10 | Increase if tolerated and needed |
| 17-20 | 12.5 | Increase if tolerated |
| 21→ | 15 | Maximum dose |
Zepbound and Mounjaro injections come in various forms and strengths.
Single dose, pre-filled pens or single dose vials each containing:
- One 2.5 mg/0.5 mL
- One 5 mg/0.5 mL
- One 7.5 mg/0.5 mL
- One 10 mg/0.5 mL
- One 12.5 mg/0.5 mL
- One 15 mg/0.5 mL
Multi-dose vial or single-patient-use KwikPen® each containing:
- Four 2.5 mg/0.6 mL doses,
- Four 5 mg/0.6 mL doses,
- Four 7.5 mg/0.6 mL doses
- Four 10 mg/0.6 mL doses
- Four 12.5 mg/0.6 mL doses
- Four 15 mg/0.6 mL doses
This list may look overwhelming, but your healthcare provider will explain how to measure and administer the correct tirzepatide dosage, depending on which one they’ve prescribed.
Dosing of Brand vs. Compounded Tirzepatide
It’s important to realize that compounded medication is not identical to branded versions. Let’s chat about what compounded medication means exactly.
They are versions of the original medication made by licensed pharmacies; however, they:
- Are not FDA-approved.
- Contain varied tirzepatide concentrations.
- Might have extra ingredients.
This means you should always double-check the compounded tirzepatide label and the compounding pharmacy’s dosing instructions for the batch you are using.
Expected Results and Timeframes
So, how long must you wait to feel and see the effects of tirzepatide?
People report decreased appetite as early as one week, and significantly less hunger, reduced eating, and fewer cravings starting between weeks 3 and 8.
With regards to weight loss, everyone’s result will differ, but in general, trials found:
- A weight loss of 20% from baseline at 72 weeks.
- Around 8 out of 10 patients lost ≥ 10% body weight at 72 weeks.
- People in the tirzepaеide group often noticed changes as early as 4 weeks .
Looking at 7 trials, on average, the therapeutic dose of tirzepatide giving the most meaningful weight loss is 10 mg weekly:
| Maintenance Dose | Average difference in body weight change |
|---|---|
| 5 mg | –7.5 kg |
| 10 mg | –11.0 kg |
| 15 mg | –11.5 kg |
Importantly, to have a chance of achieving these results, you must stick to a low-calorie diet and exercise regularly.
What is Tirzepatide used for?
Tirzepatide is a prescription medication used to help manage type 2 diabetes and support weight loss in adults with obesity or overweight conditions when combined with diet and exercise.
2. Is Tirzepatide effective for weight loss?
Yes, clinical studies show Tirzepatide can significantly reduce body weight by improving appetite control, blood sugar regulation, and metabolism.
3. How does Tirzepatide work?
Tirzepatide works by activating GIP and GLP-1 hormone receptors, which help regulate blood sugar levels, reduce appetite, and slow digestion.
4. What are the side effects of Tirzepatide?
Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite. Most side effects are mild and improve over time.
5. How is Tirzepatide taken?
Tirzepatide dosage chart for weight loss is taken as a once-weekly injection under the skin, usually in the abdomen, thigh, or upper arm.
6. How long does Tirzepatide take to work?
Some people notice reduced appetite within a few weeks, while significant weight loss and blood sugar improvements may take several months.
7. Who should not take Tirzepatide?
People with a history of medullary thyroid cancer, severe gastrointestinal disease, or allergy to the drug should avoid it unless advised by a doctor.
8. Can Tirzepatide be used without diabetes?
Yes, it may be prescribed for weight management in people without diabetes, depending on medical approval and guidelines.
9. Do you need a prescription for Tirzepatide?
Yes, Tirzepatide is a prescription-only medication and must be prescribed by a licensed healthcare provider.
10. What is the difference between Tirzepatide and Semaglutide?
Tirzepatide targets both GIP and GLP-1 receptors, while Semaglutide mainly targets GLP-1. This dual action may lead to greater weight loss in some patients.
